IP Library Granted Patent US 9,320,808
Granted Patent B2
US 9,320,808 · App. 14/284,067 · Granted Apr 26, 2016

Acid salt forms of polymer-drug conjugates and alkoxylation methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,320,808
App. No.
14/284,067
Granted
Apr 26, 2016
Kind
B2
Abstract

Among other aspects, provided herein is a mixed-acid salt of a water-soluble polymer-drug conjugate, along with related methods of making and using the same. The mixed-salt acid salt is stably formed, and appears to be more resistant to hydrolytic degradation than the corresponding predominantly pure acid salt or free base forms of the polymer-drug conjugate. The mixed acid salt is reproducibly prepared and recovered, and provides surprising advantages over non-mixed acid salt forms of the water-soluble polymer drug conjugate.

Claims (2)

1. A composition comprising mixed counter-ions of salts of water-soluble polymer-active agent conjugates having at least one basic tertiary amine group, and further wherein for each tertiary amine group, the tertiary amine group is either protonated or unprotonated, where any given protonated tertiary amine group is an acid salt form of an inorganic acid or trifluoroacetic acid (TFA), and further wherein the water-soluble polymer-active agent conjugates have the following structure

wherein n is an integer ranging from about 20 to about 500, and further wherein at least 25 mole percent of the tertiary amine groups are protonated as the TFA salt, wherein about 25-40 mole percent of the tertiary amine groups are protonated as the HC1 salt, and about 5-35 mole percent of the tertiary amine groups within the active agent are non-protonated.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 33105, FRAME 0898 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036855/0524 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
SECURITY INTEREST Recorded Jun 9, 2014
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 033105/0898 →